N, S., & M, S. (2024). From metabolomics to proteomics: Understanding the role of dopa decarboxylase in Parkinson's disease. Scientific commentary on: "Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson's disease". Acta neuropathologica, 147(1), 88. https://doi.org/10.1007/s00401-024-02739-5
Chicago Style (17th ed.) CitationN, Shebl, and Salama M. "From Metabolomics to Proteomics: Understanding the Role of Dopa Decarboxylase in Parkinson's Disease. Scientific Commentary on: "Comprehensive Proteomics of CSF, Plasma, and Urine Identify DDC and Other Biomarkers of Early Parkinson's Disease"." Acta Neuropathologica 147, no. 1 (2024): 88. https://doi.org/10.1007/s00401-024-02739-5.
MLA (9th ed.) CitationN, Shebl, and Salama M. "From Metabolomics to Proteomics: Understanding the Role of Dopa Decarboxylase in Parkinson's Disease. Scientific Commentary on: "Comprehensive Proteomics of CSF, Plasma, and Urine Identify DDC and Other Biomarkers of Early Parkinson's Disease"." Acta Neuropathologica, vol. 147, no. 1, 2024, p. 88, https://doi.org/10.1007/s00401-024-02739-5.